• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

持久存在的移植物来源供体T细胞促成小鼠慢性移植物抗宿主病的发病机制。

Long-Lasting Graft-Derived Donor T Cells Contribute to the Pathogenesis of Chronic Graft-versus-Host Disease in Mice.

作者信息

Kosugi-Kanaya Mizuha, Ueha Satoshi, Abe Jun, Shichino Shigeyuki, Shand Francis H W, Morikawa Teppei, Kurachi Makoto, Shono Yusuke, Sudo Naoto, Yamashita Ai, Suenaga Fumiko, Yokoyama Akihiro, Yong Wang, Imamura Masahiro, Teshima Takanori, Matsushima Kouji

机构信息

Department of Molecular Preventive Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

CREST, Japan Science and Technology Agency, Tokyo, Japan.

出版信息

Front Immunol. 2017 Dec 18;8:1842. doi: 10.3389/fimmu.2017.01842. eCollection 2017.

DOI:10.3389/fimmu.2017.01842
PMID:29326717
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5741650/
Abstract

Chronic graft-versus-host disease (cGVHD) is a major complication in long-term survivors of allogeneic hematopoietic stem cell transplantation (allo-HSCT). Graft-derived T cells (T) have been implicated in the induction of cGVHD; however, the extent of their contribution to the pathogenesis of cGVHD remains unclear. Using a mouse model of cGVHD, we demonstrate that T predominate over hematopoietic stem cell-derived T cells generated (T) in cGVHD-affected organs such as the liver and lung even at day 63 after allo-HSCT. Persisting T, in particular CD8 T, not only displayed an exhausted or senescent phenotype but also contained a substantial proportion of cells that had the potential to proliferate and produce inflammatory cytokines. Host antigens indirectly presented by donor HSC-derived hematopoietic cells were involved in the maintenance of T in the reconstituted host. Selective depletion of T in the chronic phase of disease resulted in the expansion of T and thus neither the survival nor histopathology of cGVHD was ameliorated. On the other hand, T depletion caused activation of T and resulted in a lethal T-mediated exacerbation of GVHD. The findings presented here clarify the pathological role of long-lasting T in cGVHD.

摘要

慢性移植物抗宿主病(cGVHD)是异基因造血干细胞移植(allo-HSCT)长期存活者的主要并发症。移植物来源的T细胞(T)被认为与cGVHD的发生有关;然而,它们对cGVHD发病机制的贡献程度仍不清楚。使用cGVHD小鼠模型,我们证明即使在allo-HSCT后63天,在受cGVHD影响的器官如肝脏和肺中,T细胞在数量上也超过造血干细胞来源的T细胞(T)。持续存在的T细胞,特别是CD8 T细胞,不仅表现出耗竭或衰老的表型,而且含有相当比例具有增殖和产生炎性细胞因子潜力的细胞。供体造血干细胞来源的造血细胞间接呈递的宿主抗原参与了重建宿主体内T细胞的维持。在疾病的慢性期选择性清除T细胞导致T细胞扩增,因此cGVHD的生存率和组织病理学均未改善。另一方面,清除T细胞导致T细胞活化,并导致致命的T细胞介导的移植物抗宿主病加重。本文的研究结果阐明了持久存在的T细胞在cGVHD中的病理作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c906/5741650/2ab209bd17d2/fimmu-08-01842-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c906/5741650/89d1db88512f/fimmu-08-01842-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c906/5741650/d6cca35a11c3/fimmu-08-01842-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c906/5741650/3500f4c4479d/fimmu-08-01842-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c906/5741650/96ba7c704945/fimmu-08-01842-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c906/5741650/5e03ade7f1e0/fimmu-08-01842-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c906/5741650/ebd0284e8291/fimmu-08-01842-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c906/5741650/2ab209bd17d2/fimmu-08-01842-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c906/5741650/89d1db88512f/fimmu-08-01842-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c906/5741650/d6cca35a11c3/fimmu-08-01842-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c906/5741650/3500f4c4479d/fimmu-08-01842-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c906/5741650/96ba7c704945/fimmu-08-01842-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c906/5741650/5e03ade7f1e0/fimmu-08-01842-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c906/5741650/ebd0284e8291/fimmu-08-01842-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c906/5741650/2ab209bd17d2/fimmu-08-01842-g007.jpg

相似文献

1
Long-Lasting Graft-Derived Donor T Cells Contribute to the Pathogenesis of Chronic Graft-versus-Host Disease in Mice.持久存在的移植物来源供体T细胞促成小鼠慢性移植物抗宿主病的发病机制。
Front Immunol. 2017 Dec 18;8:1842. doi: 10.3389/fimmu.2017.01842. eCollection 2017.
2
Reconstituted CD74 NK cells trigger chronic graft versus host disease after allogeneic bone marrow transplantation.重编程的 CD74 NK 细胞在异基因骨髓移植后引发慢性移植物抗宿主病。
J Autoimmun. 2024 Jul;147:103274. doi: 10.1016/j.jaut.2024.103274. Epub 2024 Jun 26.
3
Induction of lethal graft-versus-host disease by anti-CD137 monoclonal antibody in mice prone to chronic graft-versus-host disease.抗CD137单克隆抗体在易患慢性移植物抗宿主病的小鼠中诱导致死性移植物抗宿主病。
Biol Blood Marrow Transplant. 2009 Mar;15(3):306-14. doi: 10.1016/j.bbmt.2008.11.035.
4
Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.骨髓间充质干细胞可降低异基因造血干细胞移植后的急性移植物抗宿主病。
Immunol Invest. 2008;37(1):29-42. doi: 10.1080/08820130701410223.
5
Chronic graft-versus-host disease of the kidney in patients with allogenic hematopoietic stem cell transplant.同种异体造血干细胞移植后患者的慢性移植物抗宿主病的肾脏表现。
Eur J Haematol. 2013 Aug;91(2):129-34. doi: 10.1111/ejh.12149. Epub 2013 Jun 28.
6
Altered immune reconstitution of B and T cells precedes the onset of clinical symptoms of chronic graft-versus-host disease and is influenced by the type of onset.B细胞和T细胞免疫重建改变先于慢性移植物抗宿主病临床症状出现,并受发病类型影响。
Ann Hematol. 2017 Feb;96(2):299-310. doi: 10.1007/s00277-016-2881-x. Epub 2016 Dec 9.
7
Reduction of Foxp3+ T cell subsets involved in incidence of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后,参与慢性移植物抗宿主病发生的Foxp3 + T细胞亚群减少。
Hematol Oncol. 2017 Mar;35(1):118-124. doi: 10.1002/hon.2255. Epub 2015 Oct 6.
8
IL-39 promotes chronic graft-versus-host disease by increasing T and B Cell pathogenicity.白细胞介素-39通过增加T细胞和B细胞的致病性来促进慢性移植物抗宿主病。
Exp Hematol Oncol. 2022 Jun 2;11(1):34. doi: 10.1186/s40164-022-00286-x.
9
Chronic graft-versus-host-disease in CD34(+)-humanized NSG mice is associated with human susceptibility HLA haplotypes for autoimmune disease.CD34(+)-人源化 NSG 小鼠中的慢性移植物抗宿主病与人类自身免疫性疾病易感 HLA 单倍型相关。
J Autoimmun. 2015 Aug;62:55-66. doi: 10.1016/j.jaut.2015.06.006. Epub 2015 Jul 3.
10
Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.供体淋巴细胞输注后的移植物抗白血病反应和移植物抗宿主反应由宿主型抗原呈递细胞启动,并在早期和长期嵌合体中由调节性T细胞调节。
Biol Blood Marrow Transplant. 2006 Apr;12(4):397-407. doi: 10.1016/j.bbmt.2005.11.519.

引用本文的文献

1
Inflammation-induced epigenetic imprinting regulates intestinal stem cells.炎症诱导的表观遗传印记调控肠道干细胞。
Cell Stem Cell. 2024 Oct 3;31(10):1447-1464.e6. doi: 10.1016/j.stem.2024.08.006. Epub 2024 Sep 3.
2
Naïve Primary Mouse CD8 T Cells Retain Immune Responsiveness After Electroporation-Based CRISPR/Cas9 Genetic Engineering.未经处理的原代小鼠CD8 T细胞在基于电穿孔的CRISPR/Cas9基因工程后仍保留免疫反应性。
Front Immunol. 2022 Jun 30;13:777113. doi: 10.3389/fimmu.2022.777113. eCollection 2022.
3
High proportions of CD3 T cells in grafts delayed lymphocyte recovery and reduced overall survival in haploidentical peripheral blood stem cell transplantation.

本文引用的文献

1
Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation.移植后环磷酰胺用于预防 HLA 匹配的动员血细胞移植后的移植物抗宿主病。
Blood. 2016 Mar 17;127(11):1502-8. doi: 10.1182/blood-2015-10-672071. Epub 2016 Jan 13.
2
Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease.抗淋巴细胞球蛋白预防慢性移植物抗宿主病。
N Engl J Med. 2016 Jan 7;374(1):43-53. doi: 10.1056/NEJMoa1506002.
3
Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults.
在单倍体相合外周血干细胞移植中,移植物中高比例的CD3 T细胞会延迟淋巴细胞恢复并降低总体生存率。
Mol Clin Oncol. 2020 Jun;12(6):574-580. doi: 10.3892/mco.2020.2027. Epub 2020 Apr 2.
4
Determining the Quantitative Principles of T Cell Response to Antigenic Disparity in Stem Cell Transplantation.确定干细胞移植中抗原差异的 T 细胞反应的定量原则。
Front Immunol. 2018 Oct 11;9:2284. doi: 10.3389/fimmu.2018.02284. eCollection 2018.
老年患者接受非清髓性 HLA 半相合血液或骨髓移植并联合大剂量移植后环磷酰胺的疗效
J Clin Oncol. 2015 Oct 1;33(28):3152-61. doi: 10.1200/JCO.2014.60.4777. Epub 2015 Aug 10.
4
HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide after Busulfan-Containing Reduced-Intensity Conditioning.含白消安的减低剂量预处理后行移植后环磷酰胺的HLA单倍型相合外周血干细胞移植
Biol Blood Marrow Transplant. 2015 Sep;21(9):1646-52. doi: 10.1016/j.bbmt.2015.06.008. Epub 2015 Jun 18.
5
Loss of lymph node fibroblastic reticular cells and high endothelial cells is associated with humoral immunodeficiency in mouse graft-versus-host disease.淋巴结成纤维细胞网状细胞和高内皮细胞的缺失与小鼠移植物抗宿主病中的体液免疫缺陷相关。
J Immunol. 2015 Jan 1;194(1):398-406. doi: 10.4049/jimmunol.1401022. Epub 2014 Nov 24.
6
Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans.慢性移植物抗宿主病和闭塞性细支气管炎需要增加滤泡辅助性T细胞和生发中心B细胞。
Blood. 2014 Jun 19;123(25):3988-98. doi: 10.1182/blood-2014-03-562231. Epub 2014 May 12.
7
Bone marrow graft-versus-host disease: evaluation of its clinical impact on disrupted hematopoiesis after allogeneic hematopoietic stem cell transplantation.骨髓移植物抗宿主病:评价其对异基因造血干细胞移植后造血功能紊乱的临床影响。
Biol Blood Marrow Transplant. 2014 Apr;20(4):495-500. doi: 10.1016/j.bbmt.2013.12.568. Epub 2013 Dec 27.
8
The immunoproteasome in antigen processing and other immunological functions.免疫蛋白酶体在抗原加工和其他免疫功能中的作用。
Curr Opin Immunol. 2013 Feb;25(1):74-80. doi: 10.1016/j.coi.2012.11.004. Epub 2012 Dec 6.
9
Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans.供者 B 细胞同种异体抗体沉积和生发中心形成是导致小鼠慢性移植物抗宿主病和细支气管炎性闭塞发展所必需的。
Blood. 2012 Feb 9;119(6):1570-80. doi: 10.1182/blood-2011-07-364414. Epub 2011 Nov 9.
10
T cell exhaustion.T 细胞耗竭。
Nat Immunol. 2011 Jun;12(6):492-9. doi: 10.1038/ni.2035.